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Abstract
Calmodulin is the natural substrate for ubiquitin-ligation by the enzyme ubiquitin-calmodulin ligase uCaM-synthetase;
. 2qEC 6.3.2.21 . The activity of this ligase is regulated by the binding of the second messenger Ca to the substrate
calmodulin, which increases the activity ca. 10-fold. Up till now, two components of the ligase could be identified: uCaM
Syn-F1 and uCaM Syn-F2, the first of which binds to ubiquitin and the second which binds to calmodulin. Since the
physiological role of this enzyme is still unclear, this study was designed to examine whether the activity of uCaM-Syn-
thetase in 40 000=g tissue supernatants correlates with the calmodulin content in the various tissues. In reticulocytes,
spleen, erythrocytes, testis and brain, which are rich in uCaM synthetase, the tissue contents calculated on the basis of
activity measurements were between 4–80-fold higher than in red and white skeletal muscle. These activities did not
correlate with the respective calmodulin contents of the tissues indicating that other factors were determining these enzyme
levels. A second aim was to gain information on the role of the ATP-ubiquitin-dependent proteolytic pathway in those
tissues displaying uCaM synthetase activity. In the reticulocyte system which contains the classical ATP-ubiquitin-depen-
dent proteolytic pathway as measured with 125I-BSA, no ubiquitin-dependent degradation of calmodulin could be detected.
We therefore examined the other tissues of the rabbit with the substrate 125I-BSA and succeeded in finding a ubiquitin-inde-
pendent ATP-dependent proteolytic activity in every case but no ubiquitin-dependent activity. The ubiquitin-independent
activity was highest in smooth muscle and red skeletal muscle being ca. 3–4-fold higher than in lung and testis. In 50% of
the tissue crude extracts the time curve of calmodulin ubiquitylation progressed through a maximum indicating a dynamic
steady state based on conjugate synthesis and decay. If a ubiquitylation pulse of 30 min was followed in liver crude extracts
by the addition of EGTA, which specifically inhibits ubiquityl-calmodulin synthesis, a half-life of calmodulin-conjugate
decay of 15–20 min is observed. A similar conjugate half-life of ca. 30 min was observed after addition of EDTA excluding
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that conjugate decay is due to an ATP-dependent proteolytic process. Studying the decay of purified ubiquitin-125I-BH-
calmodulin conjugates in cell-free reticulocyte extracts led to the discovery of an ATP-independent isopeptidase activity
which splits ubiquitin-calmodulin conjugates without leading to detectable calmodulin fragments. The rapid decay of
ubiquitin-calmodulin conjugates in tissue extracts can therefore be plausibly explained by a ubiquityl-calmodulin splitting
isopeptidase activity. q 1997 Elsevier Science B.V.
Keywords: Calmodulin; Ubiquitin ligase; Ubiquityl-calmodulin synthetase; Ubiquityl-calmodulin isopeptidase; ATP-dependent proteoly-
sis
1. Introduction
Ubiquitin calmodulin ligase uCaM synthetase, EC
. w x6.3.2.21 1–3 was the second defined ubiquitin
ligase system discovered. It is responsible for the
Ca2q-dependent conjugation of calmodulin with ubiq-
uitin in eukaryotic organisms from yeast to mammals
 w x.for review see 4 and the catalyzed reaction can be
described according to the following equation n is
.an integer :
calmodulinqn ubiquitinqn ATP
Ca2q
| ubiquitin ycalmodulinqn AMPqn PPi . n
1 .
Experiments in vitro suggest that ubiquitylation de-
creases the biological activity of the Ca2q-regulator
w xprotein 4,5 .
The calmodulin ubiquitylating enzyme system Eq.
 ..1 can be differentiated from the fairly unspecific
ubiquitin-protein ligase system EC 6.3.2.19; for re-
w x.views see 4,6 which typically catalyzes the ubiqui-
tylation of various artificial protein substrates in
w xreticulocytes 7,8 according to the N-end rule
 .ATP-ubiquitin-dependent proteolytic pathway . Be-
sides the ATP-ubiquitin-dependent proteolytic sys-
tem, which contains the ATP-dependent-26-S-pro-
tease, other ubiquitin-independent systems have also
w xbeen described 9–13 . An ATP-dependent protease
of this type from cardiac muscle which we described
w x w x11 has a molecular mass of 310–350 kDa 11,14 , is
w xubiquitin-independent, and can be differentiated 14
from the other major higher molecular mass proteases
 w x.for reviews see 15,16 such as the 20S multicat-
 .alytic-endopeptidase-complex EC 3.4.99.46 and the
ATP-dependent-26-S-protease.
As yet little is known about the distribution of
ubiquitin ligases in general and the different ATP-de-
pendent proteolytic activities in mammalian tissues.
In addition the mechanism and regulation of the
physiological degradation of intracellular proteins un-
w xder steady state conditions is still a major enigma 4 .
In this paper the specific Ca2q-dependent ubiqui-
tin-calmodulin ligase and the ATP-dependent prote-
 .olytic acti˝ity ubiquitin dependent and independent
as measured with the classical artificial substrate
125 w xI-BSA 17–20 were determined in various rabbit
tissues. Both the ligase and an ATP-dependent prote-
olytic activities could be detected in all organs tested.
In many cases the synthesized ubiquitin-calmodulin
conjugates exhibited a dynamic state, resulting from a
strong opposing reaction to ubiquityl-calmodulin syn-
thesis. Evidence is presented which suggests that this
opposing reaction is due to isopeptidase activity.
2. Materials
Ubiquitin, phenylhydrazine and Fluphenazine were
 . purchased from Sigma Munich . Creatine kinase EC
.  .2.7.3.2 was from Boehringer Mannheim . Leupeptin
 .and dithioerythritol DTE were obtained from Biomol
 . Hamburg . Coomassie Brilliant Blue R-250 sServa
.Blue R , BSA, deoxyglucose and 2,4 dinitrophenol
 .were obtained from Serva Heidelberg . Evipan
 . hexobarbital was obtained from Bayer AG Lever-
.kusen . Silicone spray was obtained from Rusch AG¨
 .Kernen-Rommelshausen . The molecular weight
standards for SDS-PAGE bovine serum albumin
 .BSA 66 kDa, ovalbumin 45 kDa, glyceraldehyde
3-phosphate dehydrogenase 36 kDa, carbonic anhy-
dratase 29.2 kDa, trypsinogen 25 kDa, trypsin in-
hibitor 20.1 kDa and lactalbumin 14.2 kDa were
 .obtained from Sigma Munich . Sepharose 6B and
DEAE-Sephacel were purchased from Pharmacia
 .Freiburg . XM100 ultrafilters for pressure filtration
on Amicon cells were obtained from Amicon Wit-
.  .ten . Enhancer foils Cronex Lightning Plus were
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 .obtained from Dupont Neu Isenburg . X-ray films
 .  .Fuji RX, NIF were obtained from Fuji Dusseldorf .¨
All chemicals were of the highest available or analyt-
ical grade. Water was deionized, distilled and then
 .passed through a Milli-Q-system Millipore, Witten
before use.
3. Methods
3.1. Preparati˝e methods
3.1.1. Reticulocytes
 .Reticulocyte-rich ca. 85% blood was generated
 .in rabbits 3–4 kg, obtained from a local dealer by
w xthe phenylhydrazine method 21 as described previ-
w x  .ously 11 . In this procedure, 2.5% wrv phenylhy-
drazine in 0.9% NaCl, pH 7.4, is injected s.c. into the
back of rabbits. On days 1–4 an amount of 0.22
mlrkg and on day 5 an amount of 0.13 mlrkg was
injected. On day 8 rabbits were given a lethal over-
 .dose of 2.5 ml Evipan 100 mgrml and bled for
harvesting of reticulocytes by incision of the jugulars.
Coagulation was inhibited by addition of 1 M sodium
citrate, pH 7.4, to a final concentration of 10 mM
into polyethylene beakers coated with silicone spray.
All further work was performed with beakers and
tubes siliconized in this way. The reticulocytes were
washed twice at 58C in a 10-fold volume of buffer
containing 10 mM potassium phosphate, 0.15 M
 .NaCl, pH 7.4 sbuffer A .
3.1.2. Reticulocyte and erythrocyte lysates.
The washed reticulocytes were depleted of ATP as
w xpreviously described 11 by incubation in 10 mM
2-deoxyglucose and 0.1 mM 2,4-dinitrophenol in
w xbuffer A for 1 h at 378C 22 and were then washed
twice in buffer A. Lysis was obtained by addition of
1.5 vol 1.66 mM DTE to the packed cells. The lysed
fraction was centrifuged for 90 min at 80 000=g to
remove particulate and membranous material and
 .stored frozen at y808C s reticulocyte lysate . Ery-
throcyte lysate was prepared in a similar manner
except that the cells were washed 3 times and ATP-
depletion step was omitted.
3.1.3. Tissue extracts
Rabbits were given a lethal overdose of Evipan
 .see above and immediately exsanguinated by decap-
itation and suspending from the hind legs. The ex-
cised tissues were extensively washed with water to
remove residual blood. Rabbit hearts were dissected
to remove the residual blood in the heart chambers.
The excised tissue was cut into small pieces and
immediately frozen in liquid nitrogen. The frozen
tissue was then transferred to a y808C freezer and
stored. For the described experiments the tissues of
five rabbits were pooled. In control experiments
 .cardiac muscle, reticulocytes the activities in fresh
and frozen tissues were compared and found to yield
 .equal results not shown . The preparation of tissue
extracts is based on the previously described proce-
w xdure 11 . According to this method 6 g of frozen
 .  .y808C rabbit tissue pooled from 5 rabbits was
homogenized in 3 mM potassium phosphate, 5 mM
EDTA, 1 mM DTE, 5 mgrml leupeptin, pH 7.4
 . buffer B in a Buhler homogenizer E. Buhler,¨ ¨
.Bodelshausen at full speed for 1 min at 48C. This
homogenate was centrifuged at 40 000=g for 30
min in a Beckman L-7r80 ultracentrifuge and the
 .supernatant scrude extract was collected as previ-
w xously described in Ref. 11 . In contrast to the intact
tissues the tissue crude extracts could not be stored
frozen. Therefore only activities measured in crude
extracts freshly prepared from frozen tissues are
shown.
3.1.4. DEAE-Sephacel chromatography
The DEAE-cellulose method employed for the en-
richment of the tissue extracts and previously de-
w xscribed in Ref. 11,23 is based on the method of
preparing the ATP-dependent proteolytic fraction II
w x3,20,22 also called APF II. In this step, proteins like
hemoglobin, myoglobin and especially ubiquitin see
w x.Ref. 22 run unadsorbed through the column. Ubiq-
uitin conjugating activity including uCaM-synthetase
w x20 , calmodulin and many other proteins are ad-
sorbed, enriched and then desorbed with KCl see
.below . APF II pools were stored frozen at y808C in
aliquots. In all cases the activities in stored APF II
pools were measured within 24 h and aliquots were
thawed only once.
3.1.4.1. Reticulocyte lysate. 14 ml of Iysate 40–50
.mgrml was fractionated on 11 ml DEAE cellulose
DEAE-Sephacel, Pharmacia, Freiburg, 1.4 cm i.d.=
.7.2 cm gel height in 3 mM KH PO rK HPO , 12 4 2 4
 . w xmM DTE, pH 7.0 buffer C 11 . The total adsorbed
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 .protein which is step-eluted vol: 25–35 ml by addi-
w x tion of 500 mM KCl 11,22 to buffer D 20 mM
.TrisrHCl, 1 mM DTE, 5 mgrml leupeptin, pH 7.2
was concentrated 4–8-fold by ammonium-sulfate pre-
 .cipitation 90% saturation and dialyzed against 20
mM TrisrHCl, 1 mM DTE, 5 mgrml leupeptin, pH
 .7.6 buffer E yielding reticulocyte APF II.
3.1.4.2. Tissue extracts and erythrocyte lysate. 10–15
ml of tissue crude extracts derived from 6 g of
homogenized tissue 10–30 mgrml; exception eye
. lens: 106 mgrml or 14 ml erythrocyte lysate 35
.mgrml were applied to 4 ml DEAE-Sephacel
 .columns 1.4 cm i.d.=2.6 cm gel height in buffer C
and then after washing protein was desorbed in one
step by increasing the KCl concentration to 350 mM
w x  .3,11,20,23 . The eluate pools 16–25 ml were pres-
sure concentrated in Amicon cells on XM 100 filters
to 1r3–1r5 of the original volume s tissue APF
.II . The run-through contained maximally ca. 10% of
 .the applied enzyme activities except for uterus 35%
 .and spleen 25% .
3.1.5. Ubiquitin
w xUbiquitin was prepared according to 11 or pur-
 .chased from Sigma Munich . Both the self-prepared
and the commercial ubiquitins were tested for biolog-
ical activity. The ubiquitin concentration necessary
for half-maximal activation of ATP-dependent prote-
olysis as tested with reticulocyte APF II was 1.5–2
 w x. mM see Ref. 11 . Ubiquitin sdes-gly-gly ubiqui-t
.tin , which cannot be conjugated to ubiquitin was
w xprepared according to 24 . For the preparation of
ubiquitin reaction mixtures contained in a total vol-t
ume of 650 ml: 37 mgrml ubiquitin, 0.37 mgrml
trypsin, 50 mM NH HCO r pH 7.8, 50 mM NaCl4 3
and 2 mM Ca2q. The reaction was stopped after 30
 .min by adding 120 ml trypsin inhibitor 10 mgrml .
The formed ubiquitin was dialyzed in Centricon 10t
tubes against 20 mM TrisrpH 7.5, 1 mM DTE and
stored frozen at y808C. 125I-labeled ubiquitin was
synthesized according to the chloramine-T procedure
 125 8 . w xi.e. I-CT-ubiquitin, 0.1–8P10 cpmrmg 11,25 .
3.1.6. Calmodulin
Bovine testis calmodulin was prepared as de-
w xscribed 26 . The concentration of calmodulin neces-
sary for half-maximal activation of phosphorylase
 .kinase maximal activation 6–7-fold was 30–70 nM
w x 12526 . Unlabeled and I-labeled BH-calmodulin,
which is ubiquitylated at similar rates as native
w x.calmodulin 27 was synthesized according to the
w x 125Bolton and Hunter method 27,28 . I-labeled BH-
calmodulin was methylated according to the method
w xdescribed for ubiquitin 27,29,30 . Fluphenazine-Sep-
 .harose FP-Sepharose was prepared from
w xFluphenazine and Sepharose 6B as described in 26
and employed for the purification of calmodulin and
 .for assaying uCaM-synthetase see below .
3.1.7. Ubiquityl-calmodulin
Ubiquitin conjugates of calmodulin were prepared
w x in analogy to the FP-test 2 . Reaction mixtures 10
.ml contained 50 mM TrisrHCl, 1 mM DTE, 5 mM
MgCl , 1 mM ATP, 10 mM phosphocreatine, 1.12
mM CaCl , 1 mM EGTA, 0.1 mgrml creatine ki-2
nase, 3.0 mgrml ubiquitin, 0.5 mgrml 125I-BH-
 8calmodulin specific radioactivity 25–440 = 10
.cpmrmg and 3.6 mgrml APF II at pH 8.0. The
reaction was stopped after 4 h at 378C by adding 30
ml of 20 mM sodium b-glycerophosphate, 1 mM
CaCl , pH 7.0 and heating to 968C for 10 min.2
Subsequently the mixture was placed on ice for 5
min. Denatured proteins were spun down 20 000=g ;
.15 min; 48C and the supernatant was applied at room
temperature to a Fluphenazine column 1.5 cm i.d.=
.2.8 cm gel height; 5 ml packed gel equilibrated with
20 mM sodium b-glycerophosphate, 1 mM CaCl ,2
 .pH 7.0 buffer F . The column was washed with
buffer F containing 300 mM NaCl and eluted with 20
mM sodium b-glycerophosphate, 10 mM EGTA, 500
mM NaCl, pH 7.0. The eluate was concentrated by
 .TCA precipitation 5% , the resulting pellet was neu-
tralized with 1M sodium phosphate and resuspended
in 20 mM sodium phosphate, 1 M NaCl, pH 7.0.
The conjugates were then adsorbed to a column of
Chelating Sepharose Fast Flow Fa. Merck, Darm-
.  .stadt 1.5 cm i.d.=2.8 cm gel height charged with
Cu2q and equilibrated with 20 mM sodium phos-
phate, 1 M NaCl, pH 7.0. Elution of the ubiquityl-
calmodulin conjugates was done by a series of ac-
etate buffers adjusted to different pH-values. Ubiqui-
tyl-calmodulin conjugates were eluted at pH 3.2,
concentrated and dialyzed in Centricon 10 tubes
against 10 mM sodium b-glycerophosphate, 0.1 mM
CaCl , pH 7.0.2
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3.2. Analytical methods
3.2.1. Enzyme acti˝ities
As described above crude tissue extracts and APF
II were prepared from the pooled tissues of 5 rabbits.
In all cases the preparation of extracts and APFII was
repeated independently at least once except for brain,
eye lens and uterus, which were obtained in too low
amounts. The enzyme activities measured in two such
independent preparations showed a good comparabil-
 .ity uncertainty ca. 30% . In the tissue distribution
 .studies Tables 1–4 the enzyme activities were de-
termined in identical tissue samples. The enriched
 .fractions Tables 2 and 4 were prepared from the
respective same extracts shown in Tables 1 and 3.
2q ( ) [ ]3.2.1.1. ATP r Mg -dependent protease s 11 .
Substrate in this procedure is 125I-labeled bovine
125 .serum albumin I-BSA . An amount of 25 mg
 .bovine serum albumin BSA was iodinated accord-
w xing to ref. 31 , mixed with 2.5 mg BSA, acetylated
w xaccording to ref. 24 and dialyzed against buffer G
 .20 mM TrisrHCl, pH 7.8 . It was then precipitated
 .by 5% wrv trichloroacetic acid TCA . The pellet
was taken up in 300 ml 1.0 M NaOH, diluted to a
total volume of 6.0 ml in water, heated to 608C for 15
125min and stored frozen at y808C I-BSA stock
.solution . Before use the stock solution was diluted
10–15-fold in 50 mM TrisrHCl, pH 8.0. Methylated
125 w xI-BSA was prepared according to Ref. 32 and
then treated as described above for native BSA.
w xATP-dependent proteolysis 22,24 was measured
w xas previously described and modified 11 for the
measurement of non-ATP-depleted extracts. In this
modified test the activity is measured in the presence
and absence of 10 mM EDTA. EDTA disrupts the
ATPrMg2q complex by chelating Mg2q. We there-
2q fore distinguish ATPrMg -dependent absence of
. 2q EDTA from ATPr Mg -independent activity s
.presence of EDTA . The ratio of dependent to inde-
pendent activity is termed ‘ATP-ratio’. In the heart
model a possible Mg2q-dependent activity was previ-
Table 2
ATP-dependent proteolytic activity in crude extracts of rabbit tissues b
Tissue Protein Net ATP-dependent proteolysis
Activity ATP-activity ratio Approx. tissue contents
2qqATPrMg
mgrml arb. Urml arb. Urmg arb. Urg ww2qyATPrMg
aReticulocytes 34.1 17.4"0.7 0.51 )6.0 87
Uterine smooth muscle 12.1 10.4"0.6 0.86 4.1 26
Red skeletal muscle 12.7 12.7"0.5 1.0 3.4 26
aErythrocytes 29.5 3.8"0.4 0.13 )6.0 19
Kidney 19.7 6.5"0.6 0.33 3.3 17
Cardiac muscle 10.3 9.1"0.2 0.88 6.6 17
 .Brain cerebrum 10.4 7.9"0.3 0.76 5.5 14
White skeletal muscle 17.4 7.7"0.5 0.44 4.4 14
Liver 31.0 5.9"1.1 0.19 4.0 12
Spleen 8.9 3.0"0.3 0.34 3.0 10
Eye lens 106.0 7.4"0.1 0.07 2.2 10
Lung 27.5 3.9"1.1 0.14 3.6 8
Testis 10.9 2.5"0.3 0.23 2.0 7
a  .  .Arb. Urg packed cells 3000=g not per g wet weight ww .
b Proteolytic activity was measured with 125I-BSA. Incubation mixtures in a final volume of 200 ml contained: 50 mM TrisrHCl, 1.25
125  7 .mM DTE, 5 mM MgCl , 5 mM ATP and 0.01 mgrml I-BSA 10 cpmrmg . The final protein concentration of the extract in the2
incubation mixture was one half of the protein concentration given in the table. Controls were run without ATPrMg2q. Incubation was
 .  .stopped after 60 min. The activity "SE was calculated from the linear portions of activity progress curves see Fig. 2 by linear
 . regression analysis ns5 time points including origin . A similar percentual error applies to the derived quantities i.e. specific activity
.and Organ contents . The ATP-independent activity has been subtracted so that the net ATP-dependent activity is given in the table. In
those cases where the ATP-independent activity was close to zero the values of the ATP-ratio are given as ‘)6.0’. For further details and
w xdefinition of arb. U see Section 3, the text and 11 .
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Table 3
Influence of ubiquitin on the ATP-dependent proteolytic activity in APF II of rabbit tissues b
Tissue Protein Net ATP-dependent ATP activity ratio Ubiquitin
2qmgrml proteolytic activity qATPrMg activity ratio
2qarb. Urml arb. Urmg qUbiyATPrMg
yUbi
aReticulocytes 10.0 23.0"0.6 2.3 6.2 5.5
Uterine smooth muscle 7.1 2.8"0.6 0.4 2.2 0.9
Red skeletal muscle 3.3 6.6"0.5 2.0 3.1 0.9
aErythrocytes 1.8 7.0"0.5 3.9 3.0 1.0
Kidney 5.3 3.2"0.3 0.6 2.9 0.9
Cardiac muscle 3.9 5.9"0.4 1.5 4.0 1.2
 .Brain cerebrum 4.2 4.6"0.4 1.1 2.4 0.8
White skeletal muscle 2.4 4.6"1.1 1.9 2.0 1.1
Liver 7.4 7.4"1.6 1.0 3.5 0.8
Spleen 2.9 3.5"0.3 1.2 2.5 1.0
Eye lens 29.4 2.9"0.1 0.1 1.6 1.1
Lung 2.6 0.8"0.1 0.3 1.5 1.2
Testis 5.4 4.4"0.4 0.8 4.5 1.0
a  .  .Arb. Urg packed cells 3000=g not per g wet weight ww .
b APF II was prepared from the respective corresponding extract of each tissue as depicted in Table 2. Proteolytic activity was measured
with 125I-BSA. Incubation mixtures in a final volume of 200 ml contained: 50 mM TrisrHCl, 1.25 mM DTE, 5 mM MgCl , 5 mM ATP2
125  7 . 2qand 0.01 mgrml I-BSA 10 cpmrmg . Ubiquitin concentration was 0.1 mgrml. Controls were run without ATPrMg . The
concentration of the enzyme solution was one half of the given protein concentration. For further details and definition of arb. U see
w xSection 3, Fig. 3, legend to Table 2 and Ref. 11 .
ously excluded with non-hydrolyzable ATP-analogs
w x  .11 . The incubation mixture total vol.: 0.2 ml for
ATPrMg2q-dependent activity contained as final
concentrations: 50 mM TrisrHCl, pH 8.0, 1 mM
DTE, 5 mM ATP, 5 mM MgCl , 10 mgrml 125I-BSA2
and 100 ml sample of tissue extracts. Mixtures with
buffer instead of sample were incubated as controls.
For ATPrMg2q-independent activity 10 mM EDTA
Table 4
Proteolysis of reductively methylated 125I-BSA by APF II of several tissues a
Tissue Substrate Proteolytic act. Net ATP-dependent proteolysis Substrate act. ratio
2q 2qqATPrMg yATPrMg arb. Urmg BSArBSA met
arb. Urmg arb. Urmg
Reticulocyte BSA 2.86 0.11 2.75 39.3
BSA . 0.22 0.15 0.07met
Cardiac muscle BSA 1.50 0.47 1.03 1.0
BSA . 1.60 0.58 1.02met
Liver BSA 0.54 0.26 0.28 0.9
BSA . 0.53 0.21 0.32met
Eye lens BSA 0.33 0.20 0.13 1.1
BSA . 0.36 0.24 0.12met
a 125 w xFor preparations of APF II and reductively methylated I-BSA see Section 3 and 11 . Proteolytic activity was measured with
125I-BSA. Incubation mixtures in a final volume of 200 ml contained: 50 mM TrisrHCl, 1.25 mM DTE, 5 mM MgCl , 5 mM ATP, 0.012
125  7 .mgrml I-BSA 10 cpmrmg and 0.1 mgrml ubiquitin. The concentration of reticulocyte APF II was 5.0 mgrml, cardiac muscle
APF II 2.5 mgrml, eye lens APF II 14.7 mgrml and liver APF II 3.7 mgrml. Activity was calculated after 60 min of incubation. For
w xfurther details and definition of arb. U see Section 3 and 11 .
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was added to the above mixture. When necessary 0.1
 .mgrml final concentration ubiquitin was added to
this standard assay. After incubation at 378C for a
 .given time 5–120 min 0.25 ml 10% wrv TCA and
 .0.05 ml unlabeled BSA 30 mgrml were added to
the mixtures and kept for 20 min at 08C. After
centrifugation for 2 min in an Eppendorf centrifuge
 .5415 Eppendorf, Hamburg at 16 000=g the TCA-
soluble radioactivity in the supernatant was measured
 .in a gamma counter Packard . Activity is expressed
in arb. U: 1 arbitrary unit corresponds to % proteoly-
sisrh in the standard incubation mixture of 200 ml
w x11 . The % proteolysis corresponds to the TCA-solu-
ble radioactivity divided by the TCA-precipitable
 .radioactivity in the incubation mixture s100% at
 .the beginning of the experiment i.e. at times0 .
 .The activity of 1 arb. unitrml or mg protein corre-
sponds to the activity per ml or mg of sample solu-
w xtion 11 . The activity can be calculated according to
the following equation:
arb. unit
ml
 .%proteolysis=assayvol. ml
s 2 .
 .  .  .standardassayvol. 0.2 ml =samplevol. ml =time h
In progress curves the proteolysis of 125I-BSA is
expressed in % under the standard conditions de-
scribed. For activity calculations from the progress
 .  .curves 7–9 data points the initial 4 data assay
points plus the origin were analyzed by linear regres-
 .sion. The derived increments"standard error SE
were employed for the respective calculations.
3.2.1.2. Ubiquityl-calmodulin synthetase. UCaM-syn-
thetase activity was m easured with the
w xFluphenazine-Sepharose test, i.e. FP-test 2,33 . The
 .incubation mixture 50–100 ml contained 50 mM
TrisrHCl, 1 mM DTE, 5 mM MgCl , 1 mM ATP,2
10 mM phosphocreatine, 0.1 mgrml creatine kinase,
500 mgrml calmodulin, 0.05 mgrml 125I-CT-
ubiquitin specific radioactivity 600 – 7000
.cpmrpmol , 0.9 mgrml APF II or a protein fraction
as indicated at pH 8.0. The mixtures with calcium
 2q.qCa contained 1.1 mM CaCl and 1 mM EGTA.2
 2q.The mixtures without calcium yCa only con-
tained 1 mM EGTA. After incubation at 378 for 60
 .min other times are indicated in the legend the
mixture was heated to 968C for 5 min. The samples
were placed on ice for 5 min, the denatured protein
was spun down on an Eppendorf centrifuge see
.above and the supernatant adsorbed to FP-Sepharose
w xand eluted for analysis as described previously 2,33 .
The amount of FP-Sepharose employed depended on
the amount of calmodulin in the mixture and was
held at the ratio of 100 ml packed FP-Sepharose per
100 mg of calmodulin. Enzymatic activity of uCaM-
synthetase corresponds to the transfer of one mol
ubiquitin to calmodulin per second and is expressed
in katal. The progress curves were analyzed as de-
scribed above for the proteolytic activity.
3.2.1.3. Deconjugation of calmodulin. The incubation
mixture contained in a final volume of 25–100 ml:
50 mM TrisrHCl, 1 mM DTE, pH 8.0 and the
indicated amounts of enzyme solution. After incuba-
tion at 378C for 30–60 min the mixtures were ana-
lyzed by 15% SDS-PAGE and autoradiography see
.below . Further details are given in the legend.
3.2.1.4. Proteolysis of calmodulin. In these experi-
ments the Bolton-Hunter method of 125I-labeling of
calmodulin was employed because its Ca2q-depen-
w xdent ubiquitylation properties are fully retained 27 .
The proteolysis of 125I-BH-calmodulin was measured
similarly as described above for the assay of ATP-de-
pendent proteolysis with 125I-BSA except that the
125I-BH-calmodulin concentration was increased 10-
 .fold to 100 mgrml ca. K for uCaM synthetase .0.5
The incubation mixture of 200 ml contained 50 mM
TrisrHCl, pH 8.0, 1 mM DTE, 5 mM ATP, 5 mM
MgCl , 1 mM EGTA, 16 mgrml reticulocyte lysate2 125  .and as substrate either 10 mgrml I-BSA control ,
125 125100 mgrml I-BH-calmodulin I-CaM; specific
4 . 125radioactivity 2.1P10 cpmrmg or methylated I-
125BH-calmodulin I-CaM-m; specific radioactivity
4 .1.9P10 cpmrmg respectively. Alternatively the
mixtures contained additionally 1.1 mM CaCl , s2
2q.  2q.qCa or 10 mM EDTA syATPrMg . The
mixtures were incubated at 378C for the indicated
times, precipitated with TCA and the soluble radioac-
tivity was measured as described above.
3.2.2. Other procedures
3.2.2.1. Protein. Protein was determined after TCA
 .precipitation 5% , washing and resolubilization of
the pellet in 0.1 M NaOH, 1% SDS according to the
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w x  .method of 34 on an AutoAnalyzer Technicon em-
ploying BSA as standard.
3.2.2.2. SDS-PAGE autoradiography. Unless other-
wise stated polyacrylamide gel electrophoresis in the
presence of SDS was performed on 15% gels accord-
w xing to 35 and the sample buffer for the Laemmli
w xsystem 35 additionally contained 10 mM EGTA
w x2 .The molecular weight standards for SDS-PAGE
 . 125are given under Materials see above . I-ubiquityl-
calmodulin was determined by quantitative auto-
w x radiography 23 . The obtained autoradiograms max-
.imum absorbance 1.8 A were densitometered at 659
 .nm full scale: 3.0 A, speed 15 mmrmin on a laser
 .scanner Ultroscan 2202, Pharmacia, Freiburg . The
data was directly transferred to a Shimadzu Integrator
 .C-R3A Chromatopac Shimadzu, Dusseldorf for¨
conversion settings: speed 30 mmrmin, slope 10
.mVrmin, drift 0 mVrmin, attenuation 9, width 20 s
to peak area in mV 2. For conversion of the peak area
to pmol ubiquityl calmodulin conjugate the system
w xwas calibrated as described in ref. 1 . For auto-
radiography the undried gels without prior staining
.or destaining were placed between two layers of
plastic foil in the presence of enhancer foils Cronex
.Lightning Plus, Dupont and were exposed to X-ray
 .films Fuji RX, NIF at y808C for 24–96 h as
w xrequired and developed as described 1,2,11 .
3.2.3. Nomenclature
The nomenclature employed follows the sugges-
w xtions made in 4 .
4. Results
4.1. Ubiquityl-calmodulin synthetase in rabbit tissues
For determination of catalytic rates the kinetics of
the conjugation of calmodulin with ubiquitin were
measured over a time of 120 min for each organ
tested. Since not all of these progress curves can be
presented, representative data is shown for two tis-
sues. The activity of uCaM-synthetase in reticulocyte
lysate and spleen crude extract are shown in Fig. 1.
 .In lysate Fig. 1A the conjugation of ubiquitin to
calmodulin increases linearly for about 30 min and
then reaches a plateau level. The activity of uCaM
Fig. 1. Progress curves of the ubiquitylation of calmodulin in
 .  .reticulocyte lysate A and spleen crude extract B . The incorpo-
 .ration of ubiquitin into calmodulin CaM was measured with the
 w x.FP-test see Section 3 and Refs. 2,33 . The incubation mixture
contained in a final volume of 100 ml: 50 mM TrisrHCl, 1 mM
DTE, 5 mM MgCl , 1 mM ATP, 10 mM phosphocreatine, 0.12
mM CaCl , 0.1 mgrml creatine kinase, 0.5 mgrml calmodulin,2
6.7 mgrml reticulocyte lysate or 6.7 mgrml spleen crude ex-
 7 .tract, respectively, and 0.05 mgrml ubiquitin 6P10 cpmrmg .
 . Controls were run without calmodulin. ‘ control only endoge-
.  .  .nous calmodulin , v qexogenous calmodulin, I net conju-
gation of exogenous calmodulin.
synthetase can be calculated from the linear portion
 .of the curve. In the spleen crude extract Fig. 1B the
amount of calmodulin ubiquitylated also initially in-
creases proportionally to the time approaching a
plateau but then runs through a maximum at ca. 25
min to decrease from 30 pmolrmg to 10 pmolrmg at
120 min. These latter results indicate that the amount
of conjugate formed in the plateau region or maxi-
mum corresponds not to an equilibrium but to a
steady state level due to an unknown counteracting
reaction. In 50% of the tissue extracts tested such
 .maximum time curves see Fig. 1B could be de-
 .tected also see Table 1 .
The uCaM synthetase activities in various rabbit
tissue extracts calculated from the initial increments
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 .first 20–30 min of progress curves are shown in
Table 1 in the order of the tissue contents. The
highest specific activities of uCaM synthetase 14–21
.fkatrmg are found in reticulocytes and spleen. The
specific activity of the enzyme in liver is over 6-fold
and in eye lens over 45-fold lower respectively. The
 .highest tissue contents per g wet weight are again
 .found in reticulocytes 2339 fkatrg ww and spleen
933 fkatrg ww. A low content was measured in
striated muscles and the eye lens. We then asked the
question if the tissue content of uCaM Synthetase
correlated with the calmodulin contents in mam-
w xmalian tissues 36 . Apart from reticulocytes, where
the exact tissue content of calmodulin has only esti-
mated, the spleen with a low calmodulin content of
ca. 80 mgrg has a high synthetase activity yielding a
synthetasercalmodulin activity ratio of 11.7. In con-
trast liver with the same tissue content of calmodulin
only has an activity ratio of 1.6. Tissues with the
highest contents in calmodulin such as brain or testis
have a low synthetasercalmodulin activity ratio of
0.4–0.5 similar to white skeletal muscle which how-
ever has one of the lowest calmodulin contents see
.Table 1 . Thus there appears to be no correlation
between uCaM synthetase activity content and the
calmodulin content of these tissues.
4.2. ATP-dependent proteolysis in rabbit tissues
Since ATP-ubiquitin-dependent proteolysis could
be the likely cause for decreasing ubiquitin-calmodu-
lin conjugates and thus a steady-state of conjugates,
 .the same tissue extracts see Table 1 were assayed
for ATP-dependent proteolytic activity with the clas-
sical substrate 125I-BSA and some representative
progress curves are shown. The proteolytic activity in
reticulocyte lysate and uterine smooth muscle crude
extracts in the presence and absence of ATP is
depicted in Fig. 2A and B, respectively. The prote-
olytic activity in reticulocyte lysate displays a distinct
lag phase. In addition proteolysis in the absence of
ATP is often close to zero with freshly prepared
 .substrate Fig. 2A leading to very high apparent
 .ATP-ratios. In smooth muscle extracts Fig. 2B a
linear proteolysis phase is followed by a plateau
phase and in addition a significant amount of ATP-
independent proteolytic activity can be measured.
The ATP-dependent activity is of the same magni-
Fig. 2. Progress curves of ATP-dependent proteolysis of 125I-BSA
 .in reticulocyte lysate A and uterine smooth muscle crude
 . 125extract B . Proteolytic activity was measured with I-BSA.
Incubation mixtures in a final volume of 200 ml contained: 50
mM TrisrHCl, 1.25 mM DTE, 5 mM MgCl , 5 mM ATP, 0.012
125  7 .mgrml I-BSA 10 cpmrmg and either 17.1 mgrml reticu-
locyte lysate or 6.1 mgrml uterine smooth muscle crude extract
respectively. Controls were run without ATPrMg2q. For further
w x  .  .  .details see Section 3 and 11 . ‘ -ATP, v qATP, I net
ATP-dependent activity.
 .tude as that in reticulocyte lysate Fig. 2A . Typically
the progress curves remain linear for 30–60 min
allowing for the calculation of the activities in Table
2. As can be seen the ATP-ratio observed lies be-
tween 2.0 and )6.0 clearly demonstrating that
ATP-dependent proteolytic activity can be detected in
all of these tissues. The highest tissue content of
ATP-dependent proteolytic activity is found in reticu-
 .locytes 87 arb. Urg ww . For other tissues the
content in ATP-dependent proteolysis varies between
7–26 arb. Urg ww. The ca. 4-fold decrease of the
total activity in erythrocytes versus reticulocytes is
probably due to the disappearance of the ATP-
w xubiquitin-dependent proteolysis system 37 .
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Fig. 3. Influence of ubiquitin on the ATP-dependent proteolytic
 .activity of reticulocyte APF II A , cardiac muscle APF II,
 .kidney APF II and eye lens APF II B . Net ATP-dependent
proteolytic activity was measured with 125I-BSA. Incubation
mixtures in a final volume of 200 ml contained: 50 mM TrisrHCl,
1.25 mM DTE, 5 mM MgCl , 5 mM ATP, 0.01 mgrml 125I-BSA2
 7 .10 cpmrmg and either 5.0 mgrml reticulocyte APF II, 2.2
mgrml cardiac muscle APF II, 2.7 mgrml kidney APF II or 14.7
mgrml eye lens APF II respectively. When indicated 0.1 mgrml
ubiquitin was added. For further details see Section 3 and Ref.
w x  .  .  .11 . A. reticulocyte APF II: ‘ control yubiquitin , v
 .  .qubiquitin. B. cardiac muscle APF II: ‘ control yubiquitin ,
 .  .  .  .v qubiquitin, eye lens APF II: ^ control yubiquitin , ’
 .  .  .qubiquitin, kidney APF II: I control yubiquitin , B
qubiquitin.
In order to establish whether this proteolytic activ-
ity is ubiquitin-dependent, endogenous ubiquitin in
the extracts was removed by DEAE chromatography
 .see methods . As shown in Fig. 3A and Table 3
proteolysis in reticulocyte APF II is stimulated 5–6-
fold by ubiquitin. A slight lag period is observed in
the first min. In contrast no activation by ubiquitin
 .ubiquitin activation ratio ;0.8–1.2 could be found
 .in cardiac muscle, kidney, eye lens Fig. 3B or in
any of the other tissue extracts tested in Table 3. On
the other hand the ATP ratios especially between 2.5
and 4.5 strongly indicate the presence of another
ubiquitin-independent ATP-dependent proteolytic ac-
tivity.
A possibility which had to be excluded was that
some residual endogenous ubiquitin had remained in
the enriched extracts leading to apparent indepen-
dence from exogenous ubiquitin. Therefore meth-
ylated BSA, which cannot be ubiquitylated, was tested
 .exemplary in the APF II of three tissues Table 4 .
Only in reticulocyte APF II employed as control is
the ATP dependent proteolytic activity drastically
 .reduced ca. 40-fold when the free -amino groups
in the substrate BSA have been methylated for de-
w x.gree of methylation see 27 . In contrast the energy
dependent proteolytic activity in the DEAE enriched
extracts of cardiac muscle, liver and eye lens is not
influenced by BSA methylation at all thus excluding
a ubiquitin conjugating mechanism.
4.3. Dynamics of ubiquitin-calmodulin conjugates in
cell-free extracts
Since it could be that 125I-BSA behaves differently
from calmodulin as a substrate in proteolytic assays,
calmodulin was tested directly to see if the decline in
 .activity seen in the maximum curve Fig. 1B could
be a result of the ubiquitin pathway of proteolysis.
125I-BH-calmodulin was chosen, since labeling by the
Bolton-Hunter procedure does not alter the substrate
w xproperties of calmodulin for uCaM-synthetase 27 .
Reticulocyte APF II was chosen as a representative
tissue fraction since it contained a high uCaM-syn-
 .thetase activity Table 1 and was the only fraction to
exhibit ATP-ubiquitin-dependent proteolytic activity
 .Table 3 . As is demonstrated in Fig. 4 no influence
of ubiquitin on the proteolysis of 125I-BH-calmodulin
could be detected in the presence or absence of ATP
whether high or low Ca2q concentrations were cho-
 . 2qsen Fig. 4A,B . In the absence of Ca a significant
ATP-dependent ubiquitin-independent proteolysis of
 .calmodulin is found Fig. 4B which is of a similar
activity level as the ubiquitin-dependent proteolysis
125  .of I-BSA Fig. 4C and which may indicate the
existence of a similar ubiquitin-independent protease
in reticulocytes as that found in the other tissues
 .Table 3 .
Since a protein component necessary for the degra-
dation of calmodulin could have been removed by the
ion-exchange procedure employed for the preparation
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of reticulocyte APFII, the proteolysis of calmodulin
was examined directly in lysate. As shown in Table 5
the proteolysis of 125I-BH-calmodulin in the presence
of Ca2q i.e. under conditions of calmodulin conjuga-
tion, is ATP-independent. The gross proteolytic rate
Fig. 4. Influence of ubiquitin on the ATP-dependent proteolysis
of 125I-BH-Calmodulin and 125I-BSA by reticulocyte APF II.
Incubation mixtures in a final volume of 200 ml contained: 50
mM TrisrHCl, 1.25 mM DTE, 5 mM MgCl , 5 mM ATP, 1 mM2
EGTA, 1.7 mgrml reticulocyte APF II and as substrate either
125  4 .100 mgrml I-BH-calmodulin 2.1P10 cpmrmg in A and B
125  4 .or 10 mgrml I-BSA 1.8P10 cpmrmg in C. Alternatively
 2q .the mixtures contained in addition 1.1 mM CaCl sqCa ,2
 2q .10 mM EDTA syATPrMg or 0.1 mgrml ubiquitin. The
mixtures were incubated at 378C. At the indicated times aliquots
of 20 ml were taken and precipitated with TCA. TCA soluble
peptides in the supernatant were counted as described in Meth-
ods. A. Proteolysis of 125I-BH-calmodulinqCa2q. B. Proteolysis
125 2q  . 125of I-BH-calmodulin-Ca qEGTA . C. Proteolysis of I-
 .  .  .BSA, yATP: ‘ yubiquitin, v qubiquitin; qATP: I
 .yubiquitin, B qubiquitin.
under these conditions is ca. 8-fold lower than the
proteolysis of the control substrate 125I-BSA, al-
though on a weight basis the concentration 125I-BH-
calmodulin in the assay was 10-fold higher than that
125  .of I-BSA. As in the enriched APF II Fig. 4
ATP-dependent proteolysis of 125I-BH-calmodulin is
clearly ca. 2.5–3.0-fold higher in the absence of
2q   .Ca i.e. 3.1%r ml=h than in the presence of
Ca2q i.e. under conditions where ubiquitylation of
calmodulin does not take place. From this value it
can be calculated that 0.19% of the calmodulin is
degraded per hour and per mg lysate protein with
50% of the calmodulin being degraded per mg lysate
 .protein in 250 h i.e. apparent half-life . Finally as
shown in Table 5 methylation of calmodulin, which
prohibits ubiquitylation, shows no influence on the
proteolysis of BH-calmodulin in reticulocyte lysate in
the presence of ATP thereby yielding a final argu-
ment for excluding the ubiquitin pathway as the
mode of degradation also in the cell-free extract of
 .reticulocytes lysate .
Since the decline in calmodulin conjugate level as
 .seen in spleen extract Fig. 1B was much more rapid
than any of the proteolytic rates observed above
indicated, the mechanism underlying the maximum
curves was examined in more detail in liver extract,
which showed the same behavior as spleen but could
be obtained in higher amounts. In Fig. 5 a typical
maximum curve in liver crude extract is shown. A
maximum is reached after ca. 20 min and then the
curve decreases with a half-life of ca. 55 min. Addi-
tion of 0.5 mgrml ubiquitin , which cannot bet
.conjugated to proteins , surprisingly increases the
amount of conjugate formed after 20 min by nearly
50%. In addition the decline in conjugates between
60–120 min is significantly reduced. The insert in
Fig. 5 demonstrates that the radioactivity changes
measured truly reflect the changes in conjugate levels
present in the incubation mixture.
Fig. 6 shows the influence of various parameters
on conjugate development and levels in liver crude
extract. The maximum steady state level and follow-
ing decline of conjugates is dependent on dilution
 .Fig. 6A indicating a strong dependence on the
concentration of a factor influencing enzyme activity.
A 2-fold dilution practically abolishes the decay of
 .conjugates Fig. 6A . On the other hand addition of
3.0 mgrml ubiquitin to the incubation mixture Fig.t
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.6B not only abolishes the decay but strongly en-
hances the net synthesis of ubiquityl-calmodulin
which increases to a new higher steady state. Since
w xubiquitin cannot be conjugated to proteins 24 andt
evidently does not inhibit uCaM synthetase its effect
 .must be to inhibit the opposing reaction s which
decrease the concentration of conjugates. Therefore,
 .in a third experiment Fig. 6C , performed at a higher
protein concentration to enhance the decay rate,
EDTA was added to chelate Mgqq. EDTA which
inhibits ubiquitin conjugation and all ATP-dependent
proteolytic activity strongly increases the net disap-
 .pearance of conjugates t ;30 min versus the1r2
 .control no addition, t ;45 min . If the calmod-1r2
ulin conjugates were being degraded by an ATP-de-
pendent-protease, then the addition of EDTA should
have led to a stabilization of the conjugates at a
plateau level. However this is not the case in agree-
ment with the previous experiments above. If ubiqui-
tin is added together with EDTA a plateau, stable fort
 .60 min, is obtained Fig. 6C due to a simultaneous
inhibition of the synthesis and decay of conjugates.
EGTA which selectively inhibits the Ca2q-dependent
conjugation of calmodulin leads to a somewhat faster
 .decay than EDTA alone t ;15–20 min .1r2
These results indicated that a strong activity proba-
bly unrelated to the ubiquitin proteolytic pathway,
which was too high to be of other proteolytic origin,
was counteracting the synthesis of ubiquityl-
calmodulin conjugates. Since liver was a tissue, which
in our hands did not contain the ATP-ubiquitin-de-
pendent proteolytic pathway in significant amounts,
 .Fig. 5. Progress curves of the ubiquitylation of calmodulin in a liver crude extract. The incorporation of ubiquitin into calmodulin CaM
 w x.was measured with the FP-test see Section 3 and Refs. 2,33 . The incubation mixture contained in a final volume of 100 ml: 50 mM
TrisrHCl, 1 mM DTE, 5 mM MgCl , 1 mM ATP, 10 mM phosphocreatine, 0.1 mM CaCl , 0.1 mgrml creatine kinase, 0.5 mgrml2 2
125 125  8 .non-labeled I-BH-calmodulin, 12.0 mgrml liver crude extract and 0.05 mgrml I-ubiquitin 0.3P10 cpmrmg . As indicated
incubation mixtures contained in addition 0.5 mgrml ubiquitin . The efficiency of the FP-test with 125I-BH-calmodulin is ca. 50% lesst
than with 125I-CT-ubiquitin, leading to ca. 2–3-fold lower enzyme actitivities. Controls were run without ATPrMg2q. Inset:
Autoradiogram of the incubation mixture of liver extract at various times for detection of 125I-labeled ubiquitin-calmodulin conjugates.
 w x.  .Only the monoconjugate is visualized see Ref. 23 . Lane 1: reticulocyte APF II control ; lane 2: 20 min qATP; lane 3: 20 min
 . yATP; lane 4: 90 min qATP; lane 5: 90 min yATP; lane 6: 120 min qATP; lane 7: 120 min yATP ‘ control 50 mg
125 .  .  .I-ubiquitinrml , v qubiquitin 500 mgrml .t
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Table 5
Proteolysis of non-methlyted and methylated 125I-BH-calmodulin
by reticulocyte lysate a
 .Substrate Proteolysis %r ml=h
2q 2qqATPrMg yATPrMg
2q 2q 2q 2q125 qCa yCa qCa yCa
I-BSA Control 8.8"1.1 2.4"1.0
125I-BH-CaM 1.0"0.3 3.1"0.2 1.1"0.2 1.6"0.3
125I-BH-CaM-m 1.1"0.3 2.5"0.2 0.3"0.3 0.6"0.2
a The incubation mixture of 200 ml contained 50 mM TrisrHCl,
pH 8.0, 1 mM DTE, 5 mM ATP, 5 mM MgCl , 1 mM EGTA,2
16 mgrml reticulocyte lysate and as substrate either 10 mgrml
125 125 125I-BSA, 100 mgrml I-BH-calmodulin I-BH-CaM; spe-
4 . 125cific radioactivity 2.1=10 cpmrmg or methylated I-BH-
125 4calmodulin I-CaM-m; specific radioactivity 1.9 = 10
.cpmrmg respectively. Alternatively the mixtures contained ad-
 2q . ditionaly 1.1 mM CaCl , sqCa or 10 mM EDTA s2
2q .yATPrMg . The mixtures were incubated at 378C for 60 min
during which 4 samples were taken at different time points and
precipitated with TCA and the TCA-soluble peptides in the
supernatant counted as described in Section 3.
the above experiments were repeated with a some-
what different objective in reticulocytes, where the
ubiquitin pathway could compete with the novel ac-
tivity. In Fig. 7a isolated 125I-BH-calmodulin labeled
 .ubiquitin conjugates uCaM, u CaM, u CaM were2 3
incubated with reticulocyte lysate. Within minutes
after the addition of lysate a deconjugation of ubiqui-
tin-calmodulin conjugates which is complete in 40
min leads to the generation of a strong band of intact
125  .labeled I-BH-calmodulin Fig. 7A . It should be
noted this band is time-stable for 180 min and that no
radioactive bands below the native molecular mass of
125I-BH-calmodulin indicative of other proteolytic
fragmentation can be detected. We conclude that this
conjugate decay can be attributed to a ubiquityl-
Fig. 6. Influence of dilution, ubiquitin and chelators on thet
steady state level of ubiquityl-calmodulin in liver crude extract.
 .A. Dilution. The incorporation of ubiquitin into calmodulin CaM
 w x.was measured with the FP-test see Section 3 and Refs. 2,33 .
The incubation mixture contained in a final volume of 50 ml: 50
mM TrisrHCl, 1 mM DTE, 5 mM MgCl , 1 mM ATP, 10 mM2
phosphocreatine, 0.1 mM CaCl , 0.1 mgrml creatine kinase, 0.52
mgrml calmodulin, 12 mgrml liver crude extract and 0.05
125  8 .mgrml I-ubiquitin 0.36P10 cpmrmg . In a second mixture
the crude liver extract was diluted 2-fold. Controls were run
without ATPrMg2q. B. Ubiquitin . The incorporation of ubiqui-t
 . tin into calmodulin CaM was measured with the FP-test see
w x.Section 3 and Refs. 2,33 . The incubation mixture contained in
a final volume of 100 ml: 50 mM TrisrHCl, 1 mM DTE, 5 mM
MgCl , 1 mM ATP, 10 mM phosphocreatine, 0.1 mM CaCl ,2 2
0.1 mgrml creatine kinase, 0.5 mgrml calmodulin, 8.8 mgrml
125  8liver crude extract and 0.05 mgrml I-ubiquitin 0.36P10
.cpmrmg . At the indicated times ubiquitin in a final concentra-t
tion of 3.0 mgrml was added. Controls were run without
ATPrMg2q. C. Chelators. The incorporation of ubiquitin into
 . calmodulin CaM was measured with the FP-test see Section 3
w x.and Refs. 2,33 . The incubation mixture contained in a final
volume of 100 ml: 50 mM TrisrHCl, 1 mM DTE, 5 mM MgCl ,2
1 mM ATP, 10 mM phosphocreatine, 0.1 mM CaCl , 0.1 mgrml2
creatine kinase, 0.5 mgrml calmodulin, 12.0 mgrml liver crude
 . 125extract same extract as in Fig. 5 and 0.05 mgrml I-ubiquitin
 8 .0.3P10 cpmrmg . After 30 min EGTA, EDTA or EDTA and
ubiquitin were added as indicated. Controls were run withoutt
2q  .  .ATPrMg . A. ‘ undiluted control; ^ 2-fold dilution. B.
 .  125 .  . ‘ control 50 mg I-ubiquitinrml , v qubiquitin 3t
.  .  125 .  .mgrml . C. ‘ control 50 mg I-ubiquitinrml , v
 .  .qubiquitin 10 mgrml q5 mM EDTA, ’ q5 mM EDTA,t
 .B q1 mM EGTA.
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calmodulin splitting isopeptidase activity. This
isopeptidase activity is sensitive to inhibition by
 .ubiquitin Fig. 7B with an estimated concentration of
half-maximal inhibition of ca. 0.5 mgrml ubiquitin
in a 10-min assay, thus explaining the experiments in
Figs. 6 and 7.
Fig. 7. Evidence for ubiquityl-calmodulin isopeptidase activity in reticulocyte lysate and reticulocyte APF II. A. Incubation mixtures 100
.ml for the hydrolysis of ubiquityl-calmodulin conjugates by uCaM-isopeptidase contained 50 mM Tris, 5 mM ATP, 5 mM MgCl , 1.252
125  .mM DTE, 0.1 mM CaCl , 14 mgrml I-BH-calmodulin labeled conjugates 3200 cpmrmg and 7.1 mgrml reticulocyte lysate. Control2
 2q.  2q. mixtures were run in the presence of 10 mM EDTA i.e. yMg or 1 mM EGTA i.e. yCa respectively not shown as
.  .autoradiogram . Incubation was stopped at the indicated times see graph by adding 60 ml of Laemmli sample buffer containing 10 mM
EGTA and heating to 968C for 5 min. The reaction mixtures were then analyzed on a 15% SDS-PAGE followed by autoradiography. For
further details on the incubation mixture of isopetidase and the isolation of substrate conjugates see Section 3 and the text. Lane 1: 1.4 mg
ubiquityl-125I-BH-calmodulin. Lanes 2–8: incubation time 0 to 180 min. Lane 9: 1.4 mg ubiquityl-125I-BH-calmodulinq1 mg
125  . 125I-BH-calmodulin. B. Incubation mixtures 25 ml contained 50 mM Tris, 1 mM DTE, 0.1 mM CaCl , 71 mgrml I-BH-calmodulin2
 .labeled conjugates 4900 cpmrmg , 0.6 mgrml reticulocyte APF II and the indicated amounts of ubiquitin. Incubation was stopped after
10 min by adding 60 ml of Laemmli sample buffer containing 10 mM EGTA and heating to 968C for 5 min. The reaction mixtures were
then analyzed on a 12.5% SDS-PAGE followed by autoradiography. Lane 1: no APF II added. Lane 2: 10.0 mgrml ubiquitin. Lane 3: 6.0
mgrml ubiquitin. Lane 4: 4.0 mgrml ubiquitin. Lane 5: 2.0 mgrml ubiquitin. Lane 6: 1.0 mgrml ubiquitin. Lane 7: 0.5 mgrml
ubiquitin. Lane 8: 0.25 mgrml ubiquitin. Lane 9: 0.0 mgrml ubiquitin.
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5. Discussion
It was shown that the ubiquitin-calmodulin ligase
system or uCaM-synthetase as it is also called, can be
found in the extracts of all 13 rabbit tissues tested
 .see Table 1 . The results suggest the conclusion that
all tissues containing calmodulin also contain uCaM-
synthetase. This would be in agreement with the
general finding that calmodulins from plants, fungi
and yeast can be ubiquitylated by uCaM synthetase
w x27,33 and that this enzyme activity could be identi-
w xfied in yeast 33,38 . UCaM synthetase therefore
appears to play an important but as yet not fully
understood role in all eukaryote cells. One possible
function, namely a negative modulation of the biolog-
w xical activity of calmodulin has been suggested 5 but
remains to be substantiated.
Similarly we have detected an ATP-dependent pro-
teolytic activity degrading 125I-BSA in the tissue
 .extracts tested see Table 2 . However, except in the
case of reticulocytes, this activity was ubiquitin inde-
 .pendent see Table 3 . At present the generally ac-
cepted ATP-dependent protease in the cytosol is the
w xATP-dependent-26-S-protease 39 . Together with the
ubiquitin-protein ligase system and in some cases
with the arginyl-tRNA-protein transferase it consti-
tutes the ATP-ubiquitin-dependent proteolytic path-
w xway 6 . The question arises why no ubiquitin-depen-
dent proteolysis can be detected in any other tissue
 .extract except that from reticulocytes Table 3 . A
possible answer is that one of the enzymes involved
in the ubiquitin-dependent degradation of 125I-BSA in
reticulocytes is only present at a very low level or
even possibly missing in the other tissues. Since it
has been reported that the arginyl-tRNA-protein
w xtransferase is present in all mammalian cells 40 it is
improbable that arginylation is limiting. Similarly the
20S multicatalytic endopeptidase complex, the core
of the ATP-dependent-26-S-protease, is a constituent
w xof all eukaryotic cells 41,42 . It therefore appears
unlikely that the ATP-dependent-26-S-protease is
lacking. Since the proteolysis-connected isopeptidase
activity in the ubiquitin system has been shown to be
directly associated with the ATP-dependent-26-S-pro-
w xtease 43 it is also unlikely that this activity is
lacking. Thus the ubiquitin-protein ligase system it-
w xself 44 emerges as the possible missing candidate. A
reduced or absent activity of this enzyme system in
differentiated tissues would be in agreement with the
finding that in red cells ubiquitin protein ligase disap-
pears during differentiation from reticulocytes to ery-
w xthrocytes 37,45 . The findings of this paper are
w xtherefore in agreement with the suggestion 4 that all
differentiated cell systems i.e. tissuesrorgans can be
compared biochemically to erythrocytes where ubiq-
uitin-protein ligase activity is very low or absent.
The absent ubiquitin dependence of proteolysis
found in this paper does not appear due to a prote-
olytic inactivation of ubiquitin removal of C-termi-
.nal Gly-Gly leading to ‘des-Gly-Gly ubiquitin’ as
w xreported by 46 for liver extracts, since the proteoly-
w xsis assays were performed at pH 8.0 11 . At this pH
 .value the responsible cathepsin pH optimums5.0
is itself inactive and is additionally rapidly and irre-
w xversibly inactivated 46 . In addition all extracts were
 .prepared in the presence of leupeptin see Methods .
 .Our results with methylated BSA Table 4 which
also exclude the ubiquitin mechanism in the break-
down of 125I-BSA in the tissue extracts, are supported
by the microinjection studies of 125I-BSA and 125I-
lysozyme into hepatoma tissue culture cells as de-
w xscribed by 47 . They found that methylation of the
amino groups of 125I-BSA and 125I-lysozyme had no
effect on the intracellular degradation rates of these
two proteins. They therefore concluded that 125I-BSA
and 125I-lysozyme even if microinjected as foreign
proteins into hepatoma cells are not degraded by the
w xATP-ubiquitin-dependent proteolytic pathway 47 .
The question therefore arises how the detected
ATP-dependent proteolytic activity in the various
tissues can be explained. A ubiquitin-independent
degradation by the ATP-dependent-26-S-protease by
a mechanism similar to the antizyme-dependent
w xdegradation of ornithine decarboxylase 48 is un-
likely. In addition purified ATP-dependent-26-S-pro-
tease is incapable of degrading 125I-labeled casein
w x 125 w x 12548 , I-labeled lysozyme 48 and I-labeled BSA
w x39 . Since the purified 20S multicatalytic-endo-
 .peptidase-complex ; 700 kDa only catalyzes
w xATP-independent proteolytic reactions 39,41,49,50
w xand can in fact even be inhibited by ATP 14,41,51 it
is also not a good candidate for the observed ATP-
dependence.
Since however in this paper the same substrate and
conditions have been used by us as in our first paper
w xon cardiac muscle 11 we feel that the 310–350 kDa
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ATP-dependent protease reported by us as ‘proteo-
w xkinain’ several years ago 11,14 may be the basis of
the observed ATP-dependent degradation of 125I-BSA
in the non-methylated as well as in the methylated
form. For this proteolytic activity it was also demon-
strated with non-hydrolyzable ATP-analogs that ac-
tivity is only expressed with the hydrolyzable ATP-
w x w xmoiety 11 . Besides our work 11,14 ubiquitin-inde-
pendent ATP-dependent proteolytic systems have also
w xbeen described by other groups 9,10,12,13 and it
cannot be excluded that a mixture of different pro-
teases of this type exists in tissues. However these
systems are not yet clearly defined and a molecular
mass of ca. 300 kDa was not reported by the other
groups.
w xKuehn et al. 1989 49 reported that part of their
ATP-dependent proteolytic activity found in reticu-
locytes appeared due to a contamination with a cys-
teine proteinase complexed to a -macroglobulin from1
residual blood proteins. Since the proteolytic activity
detected by us in reticulocytes can be specifically
 .stimulated 5–6-fold by ubiquitin Table 3 a contami-
nation even of our blood material with proteinase-
a -macroglobulin complexes seems unlikely. In addi-1
tion the animals used in our study were immediately
and completely exsanguinated after sacrificing in or-
der to reduce residual blood in the tissues and thereby
to eliminate a possible contamination by cysteine
proteinase-a -macroglobulin complexes. In this con-1
 .nection we also examined eye lens Tables 3 and 4
which is neither vascularized nor contains leukocytes
w x52 . In this tissue where a contamination by cysteine
proteinase-a -macroglobulin complexes can be ex-1
cluded we found a low but significant ATP-depen-
dent proteolytic activity.
One of the most intriguing findings of this paper
concerns the dynamic state of calmodulin conjugates
in the various tissues as demonstrated by so-called
maximum curves in 50% of the tissues tested Fig. 1,
. Table 1 . EDTA which inactivates the ATP-depen-
.dent-26-S-protease decreases the half-life of calmod-
ulin conjugates from ;45 min to ;30 min instead
of stabilizing the conjugate level. This therefore
makes the ATP-dependent-26-S-protease pathway
improbable as the major route of conjugate decompo-
sition. This is conclusively supported by the experi-
ment in Table 5. In reticulocyte lysate which contains
sufficient endogenous ubiquitin, an increase in the
ATP-dependent proteolysis of calmodulin in the pres-
ence of Ca2q i.e. under ubiquitylating conditions
cannot be detected. In addition methylation of
calmodulin does not reduce the proteolysis rate under
these conditions. In contrast it is consistently found
that proteolysis of calmodulin is higher in the ab-
2q sence of Ca i.e. in the presence of EGTA Table
.5 . Besides excluding a major role of calpains by the
EGTA experiment this observation is in agreement
with the in vitro findings that calmodulin is generally
stabilized by Ca2q towards the digestion with e.g.
w x w xtrypsin 53 and thrombin 54 .
All results therefore point to an ATP-independent
mechanism responsible for the disappearance of
calmodulin-conjugates which is sensitive to inhibition
 .by ubiquitin Figs. 5 and 6 . The rate of disappear-t
ance of conjugates in liver crude extract Fig. 6C;
estimated concentration of 125I-ubiquitin-calmodulin
.conjugates 5–10 mgrml can be estimated from the
 .half-life of 15–20 min to be ca. 3%r min=mg .
This compares to an over 700-fold lower ATP-inde-
pendent degradation rate of 125I-BSA in liver crude
 .extract 0.20 arb. unitrmg, Table 2 corresponding to
 .a disappearance rate of ca. 0.004%r minrmg . Since
125I-BH-calmodulin in the absence of ATP is de-
graded 2-fold slower than 125I-BSA in reticulocyte
 .lysate Table 5 it can be estimated that the decay of
calmodulin conjugates in liver APF II is at least 3
orders of magnitudes higher than the proteolysis rates
of the unconjugated calmodulin moiety alone. This
latter very slow proteolysis of calmodulin could be
due to the 20S multicatalytic endopeptidase complex
activity which can also be strongly influenced by
substrate methylation as shown for BSA and con-
w xcluded for calmodulin 55,56 . No inhibition of the
purified 20S multicatalytic endopeptidase complex
 .generous gift of Dr. L. Kuehn, Dusseldorf by ubiq-¨
uitin could be detected in the fluorogenic peptide
 .assay not shown .
In direct experiments employing ubiquitin-125I-
BH-calmodulin conjugates the question as to what
reaction leads to conjugate decay could be clarified.
 .It could be demonstrated see Fig. 7 that within 10
min ca. 50% of the calmodulin conjugates could be
deconjugated by an isopeptidase to the original 125I-
BH-calmodulin, the reaction being complete after ca.
40 min. In addition it could be shown that this
reaction can be inhibited by ubiquitin. It is concluded
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from the work in this paper that calmodulin ubiquity-
lation is reversible, and apparently does not serve to
target calmodulin to proteolysis but serves another
w xbiological function 4,57 which remains to be fully
clarified.
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